Johnson & Johnson Agrees to Pay Up to $5.5 Billion to Settle Talc Lawsuits
Johnson & Johnson (JNJ) announced that it has agreed to pay up to $5.5 billion in a settlement for remaining lawsuits related to its talc-based products, which were alleged to cause ovarian cancer. The company said the agreement aims to provide a comprehensive resolution and bring closure to these legal matters. The news came after JNJ shares rose 1.4% post-market on Monday as investors reacted positively to the announcement of a potential end to years-long litigation surrounding its talc products, including baby powder.
Tickers: $JNJ